Table 1.
Detailed information of patients with SRSH. F: female, M: male, HT: hypertension, DM: diabetes mellitus, MVR: mitral valve replacement, COPD: chronic obstructive pulmonary disease, CAD: coronary artery disease, CABG: coronary artery bypass grafting, AF: atrial fibrillation, AVR: aortic valve replacement, DVT: deep vein thrombosis, MI: myocardial infarction, PE: pulmonary embolism, CVD: cerebrovascular disease, LMWH: low-molecular-weight heparins, ASA: acetylsalicylic acid, RBC: red blood cells, FFP: fresh frozen plasma, INR: international normalized ratio, PT: prothrombin time, aPTT: activated partial thromboplastin time.
| Patient No. | Gender | Age (year) | Comorbidity | Anticoagulant and/or Antiplatelet Treatment | Physical Examination | Symptoms | Hematoma Size (mm) | Types according to the Tomography Findings | Length of Hospitalization (day) | Begin Retreatment (day) | INR | PT (sn) | aPTT (sn) | Blood Transfusion | Hemoglobin (g/dL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 52 | HT-DM- MVR-COPD | LMWH+ASA | Right lower quadrant mass | Abdominal pain | 33 | Type 2 | 5 | 5 | 1.1 | 13 | 28.4 | - | 13.6 |
|
| |||||||||||||||
| 2 | M | 47 | CAD | - | Paraumbilical mass | Abdominal pain- Nausea | 12 | Type 1 | 1 | - | 1 | 12.1 | 26.4 | - | 15.7 |
|
| |||||||||||||||
| 3 | F | 81 | AF-Constipation | Warfarin-ASA | Right lower quadrant mass | Abdominal pain | 35 | Type 2 | 4 | 4 | 5.5 | 66.9 | 171 | 1 U RBC, 1 U FFP and vitamin K |
9.2 |
|
| |||||||||||||||
| 4 | F | 74 | HT-AVR-Constipation- Obesity | Warfarin-ASA | Bilateral lower quadrant mass | Hypotension- Vomiting | 97 | Type 3 | 23 | 23 | 4.5 | 57.1 | 140 | 2 U RBC, 1 U FFP and vitamin K |
8.1 |
|
| |||||||||||||||
| 5 | F | 63 | DM-DVT story- Constipation- Obesity | LMWH | Left lower quadrant mass | Abdominal pain | 52 | Type 2 | 9 | 9 | 4.2 | 51.1 | 130 | 1 U FFP and vitamin K | 12.7 |
|
| |||||||||||||||
| 6 | M | 67 | HT-DM-CAD-Previous MI- Obesity | ASA | Right lower quadrant mass | Abdominal pain | 32 | Type 2 | 3 | 3 | 0.8 | 9.8 | 24.9 | - | 14.9 |
|
| |||||||||||||||
| 7 | F | 65 | HT-CAD- Constipation | ASA | Right upper and lower quadrant mass | Abdominal pain-Fever | 34 | Type 2 | 3 | 3 | 0.9 | 10.9 | 28 | - | 15.0 |
|
| |||||||||||||||
| 8 | F | 78 | MVR-HT-Obesity- CAD-Coronary stent | Warfarin-ASA | Right lower quadrant mass | Abdominal pain- Hypotension | 47 | Type 2 | 12 | 10 | 7 | 88.9 | 192 | 2 U FFP and vitamin K | 11.4 |
|
| |||||||||||||||
| 9 | F | 61 | PE-COPD- Obesity |
Warfarin | Right lower quadrant mass | Abdominal pain | 48 | Type 2 | 11 | 11 | 3 | 36.5 | 93.3 | 1 U FFP | 13.8 |
|
| |||||||||||||||
| 10 | F | 59 | HT-AF- COPD-Obesity |
Warfarin | Bilateral lower quadrant mass | Hypotension- Vomiting | 90 | Type 3 | 17 | 17 | 4.4 | 57.1 | 125 | 1 U RBC, 1 U FFP and vitamin K | 8.8 |
|
| |||||||||||||||
| 11 | F | 56 | HT-CAD- CABG | ASA | Right upper and lower quadrant mass | Ecchymosis | 23 | Type 1 | 2 | 2 | 1 | 12.1 | 31.1 | - | 14.3 |
|
| |||||||||||||||
| 12 | M | 71 | HT-DM-CVD | Clopidogrel | Right lower quadrant mass | Ecchymosis | 30 | Type 2 | 3 | 3 | 0.9 | 10.3 | 26.4 | - | 15.5 |
|
| |||||||||||||||
| 13 | M | 93 | HT-DM-AF- COPD-Obesity | Warfarin | Right lower quadrant mass | Abdominal pain | 32 | Type 1 | 6 | 4 | 2.5 | 30.4 | 77.7 | 1 U FFP | 14.7 |
|
| |||||||||||||||
| 14 | F | 65 | DM-Hospitalized with DVT- COPD-Obesity | LMWH | Bilateral lower quadrant mass | Abdominal pain-Sencop | 55 | Type 2 | 12 | 12 | 4 | 50 | 124 | 1 U FFP | 13.9 |